-coxib
A selective COX-2 inhibitor: an anti-inflammatory painkiller designed to spare the stomach.
- Drugs ending in -coxib: 16
- Approved somewhere: 6
- With a US drug page: 3
- Stem
- -coxib
- Class
- Selective COX-2 inhibitors: painkillers designed to spare the stomach
- Most common targets
- PTGS2 (13), CA2 (1), CA1 (1), PTGS1 (1), Cyclooxygenase 2 (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -coxib, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Celecoxib | Approved | PTGS2 | Cyclooxygenase-2 inhibitor |
| Rofecoxib | Approved | PTGS2 | Cyclooxygenase-2 inhibitor |
| Valdecoxib | Approved | PTGS2 | Cyclooxygenase-2 inhibitor |
| Etoricoxib | Approved | PTGS2 | Cyclooxygenase-2 inhibitor |
| Lumiracoxib | Approved | PTGS2 | Cyclooxygenase-2 inhibitor |
| Parecoxib | Approved | PTGS2 | Cyclooxygenase-2 inhibitor |
| Polmacoxib | Phase 3 | PTGS2, CA2, CA1 | Cyclooxygenase-2 inhibitor |
| Apricoxib | Phase 2 | PTGS2 | Cyclooxygenase-2 inhibitor |
| Cimicoxib | Phase 2 | PTGS2 | Cyclooxygenase-2 inhibitor |
| Tigemocoxib | Phase 2 | — | — |
| Imrecoxib | Phase 1 | — | — |
| Ocarocoxib | Phase 1 | — | — |
| Enflicoxib | — | PTGS2 | Cyclooxygenase-2 inhibitor |
| Firocoxib | — | PTGS2 | Cyclooxygenase-2 inhibitor |
| Mavacoxib | — | PTGS1, PTGS2 | Cyclooxygenase-1 inhibitor |
| Robenacoxib | — | PTGS2, Cyclooxygenase 2 | Cyclooxygenase-2 inhibitor |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO